Adage Capital Partners
ZURA icon

Adage Capital Partners’s Zura Bio ZURA Stock Holding History

Adage Capital Partners’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Hold
2,750,000
– – 0.02% 578
2026
Q1 		$16.4M Hold
2,750,000
– – 0.03% 552
2025
Q4 		$14.4M Sell
2,750,000
-295,444
-10% -$1.17M 0.02% 586
2025
Q3 		$13.2M Buy
+3,045,444
New +$5.48M 0.02% 580
2025
Q1 		– Sell
-300,000
Closed -$750K – 955
2024
Q4 		$750K Buy
+300,000
New +$1.07M ﹤0.01% 828

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Adage Capital Partners's ZURA Position: Q2 2026 in Review

Adage Capital Partners held its Zura Bio (ZURA) position steady in Q2 2026 at 2,750,000 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #578.

Adage Capital Partners first reported a position in ZURA in Q4 2024 and has held it in 5 quarters since. The position peaked at $16.4M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Adage Capital Partners held 2,750,000 shares of Zura Bio worth $16.2M as of Q2 2026.
  • Adage Capital Partners left its Zura Bio share count unchanged in Q2 2026.
  • Zura Bio made up 0.02% of Adage Capital Partners's portfolio in Q2 2026, its #578 holding.
  • Adage Capital Partners first reported a position in Zura Bio in Q4 2024 and has held it in 5 quarters since.
  • Adage Capital Partners's Zura Bio position peaked at $16.4M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.